Key result
Among patients with STEMI and confirmed coronary artery disease, 90% received a combination of four secondary prevention medications, while 57% were discharged on all five guideline-directed medical therapies.
Why the study?
To evaluate whether STEMI patients admitted to a community hospital were discharged on optimal medical therapy based on the latest AHA/ACC guidelines.
Observational (n=109)
No
Adherence to guideline-directed medical therapy at discharge for STEMI patients in a community hospital was suboptimal, particularly for ACEI/ARB prescription, highlighting the need for quality improvement strategies.
No takes yet. Share an insight, caveat, or question.
Adherence remains suboptimal despite gains; leaves open questions on barriers and quality improvement strategies in community STEMI care.
Latifi et al. (2020) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=109). Guideline-directed medical therapy (GDMT) was evaluated on Prescription of five guideline-directed medical therapies (dual antiplatelet therapy, β-blocker, ACEI/ARB, and statin) at discharge. Among patients with STEMI and confirmed coronary artery disease, 90% received a combination of four secondary prevention medications, while 57% were discharged on all five guideline-directed medical therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: